Rapid weight loss from GLP-1 agonists often results in excess skin and soft tissue, which creates a demand for body contouring treatments
The Wegovy pill was approved by the UK's MHRA based primarily on robust data from a large Phase 3 study called OASIS 4 , which demonstrated: Average weight loss of around 14% in the main analysis Up to 16-17% weight loss in people who stayed on their treatment plan as directed Weight loss on a completely similar scale to injectable Wegovy 2.4 mg in comparable clinical programmes Oral semaglutide is now fully approved, licensed, and available to be prescribed privately in the UK
These insights enable healthcare providers and coaches to personalize care plans, improve coaching effectiveness, and boost adherence to health goals
Note: If you have any more questions not mentioned above, please contact us at the contact number provided below
What are the possible side effects of semaglutide
Mol Neurobiol 62(12):1616816188 Weng Y, Zhang Y, Wang D et al (2023) Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1-TXNIP/ROS-NLRP3 pathway in PCOS
